Cargando…

Urinary liver-type fatty acid binding protein and chronic kidney disease

Detalles Bibliográficos
Autores principales:	Kamijo-Ikemori, A., Kimura, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588319/ https://www.ncbi.nlm.nih.gov/pubmed/26628789

Ejemplares similares

Distinct Roles of Urinary Liver-Type Fatty Acid-Binding Protein in Non-Diabetic Patients with Anemia
por: Imai, Naohiko, et al.
Publicado: (2015)

Elevation of urinary liver-type fatty acid binding protein after cardiac catheterization related to cardiovascular events
por: Kamijo-Ikemori, Atsuko, et al.
Publicado: (2015)

Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients
por: Kamijo-Ikemori, Atsuko, et al.
Publicado: (2011)

Clinical usefulness of urinary liver-type fatty-acid-binding protein as a perioperative marker of acute kidney injury in patients undergoing endovascular or open-abdominal aortic aneurysm repair
por: Obata, Yumi, et al.
Publicado: (2015)

Relationship between Urinary Liver-Type Fatty Acid-Binding Protein (L-FABP) and Sarcopenia in Spontaneously Diabetic Torii Fatty Rats
por: Tanabe, Jun, et al.
Publicado: (2020)

Clinical Utility of Urinary Biomarkers for Prediction of Acute Kidney Injury and Chronic Renal Dysfunction After Open Abdominal Aortic Aneurysm Repair
por: Obata, Yumi, et al.
Publicado: (2021)

Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease
por: Mitsides, Nicos, et al.
Publicado: (2023)

Relationship of urinary liver-type fatty acid-binding protein with cardiovascular risk factors in the Japanese population without chronic kidney disease: Sasayama study
por: Kubota, Yoshimi, et al.
Publicado: (2021)

Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation
por: Obata, Yumi, et al.
Publicado: (2023)

Urinary liver‐type fatty acid‐binding protein is independently associated with graft failure in outpatient kidney transplant recipients
por: Yepes‐Calderón, Manuela, et al.
Publicado: (2020)

The Role of Urinary Liver-Type Fatty Acid-Binding Protein in Critically Ill Patients
por: Cho, Eunjung, et al.
Publicado: (2013)

Heart-type fatty acid-binding protein (H-FABP) and coronary heart disease
por: Das, Undurti N.
Publicado: (2016)

Renal expression and urinary excretion of liver‐type fatty acid‐binding protein in cats with renal disease
por: Katayama, Masaaki, et al.
Publicado: (2020)

Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs
por: TAKASHIMA, Satoshi, et al.
Publicado: (2021)

Liver‐type fatty acid‐binding protein and neutrophil gelatinase‐associated lipocalin in cats with chronic kidney disease and hyperthyroidism
por: Kongtasai, Thirawut, et al.
Publicado: (2021)

Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
por: Panduru, Nicolae M., et al.
Publicado: (2013)

Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy
por: Viswanathan, V., et al.
Publicado: (2015)

Serum adipocyte fatty acid-binding protein in the critically ill
por: Das, Undurti N
Publicado: (2013)

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
por: Nielsen, Stine Elkjaer, et al.
Publicado: (2010)

Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis
por: Zhang, Li, et al.
Publicado: (2022)

Urinary liver‐type fatty acid‐binding protein in clinically healthy elderly cats: Evaluation of its potential to detect IRIS stage 1 chronic kidney disease and borderline proteinuria
por: Kongtasai, Thirawut, et al.
Publicado: (2022)

Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury
por: Yanishi, Masaaki, et al.
Publicado: (2022)

Urinary liver‐type fatty acid‐binding protein as a prognostic marker in patients with acute heart failure
por: Sunayama, Tsutomu, et al.
Publicado: (2021)

Urinary liver‐type fatty acid‐binding protein: A hemodynamic index during extracorporeal membrane oxygenation
por: Ichibayashi, Ryo, et al.
Publicado: (2022)

Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats
por: Inoue, Kazuho, et al.
Publicado: (2022)

Current Metabolic Status Affects Urinary Liver-Type Fatty-Acid Binding Protein in Normoalbuminuric Patients With Type 2 Diabetes
por: Ito, Hiroyuki, et al.
Publicado: (2017)

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis
por: Torigoe, Kenta, et al.
Publicado: (2020)

Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report
por: Takashima, Satoshi, et al.
Publicado: (2022)

Urinary cell‐free extrachromosomal circular DNAs: A possible biomarker for chronic kidney disease
por: Demirci, Selami
Publicado: (2022)

Lysosomal Acid Lipase Activity: A Tool for the Detection and Management of Fatty Liver Disease?
por: Ramirez, Charina M., et al.
Publicado: (2015)

Study on the correlation between urinary retinol-binding protein and nonalcoholic fatty liver disease
por: Li, Chuang, et al.
Publicado: (2021)

Impaired Citric Acid Cycle in Nondiabetic Chronic Kidney Disease
por: Jia, Zhanjun
Publicado: (2017)

Temporal changes in urinary excretion of liver-type fatty acid binding protein (L-FABP) in acute kidney injury model of domestic cats: a preliminary study
por: KATAYAMA, Masaaki, et al.
Publicado: (2019)

Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now
por: Lee, Chi Ho, et al.
Publicado: (2022)

Urinary Liver-Type Fatty-Acid-Binding Protein Predicts Long-Term Adverse Outcomes in Medical Cardiac Intensive Care Units
por: Naruse, Hiroyuki, et al.
Publicado: (2020)

Serum Liver‐Type Fatty Acid–Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma
por: Eguchi, Akiko, et al.
Publicado: (2019)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease
por: Moreno-Vedia, Juan, et al.
Publicado: (2022)

Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease
por: Li, Ben, et al.
Publicado: (2022)

What the New Definition of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Left Behind: Genetically Acquired Fatty Liver Disease (GAFLD)
por: Bril, Fernando
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_amuo1av02abispfu4942mcld93